22 Jun 2021 by admin in UncategorizedComments Tempest and Millendo Announce Stockholder Approval of Merger
21 Jun 2021 by admin in UncategorizedComments NextCure and Collaborators Publish Preclinical Data on Novel Immunomedicine NC410
07 Jun 2021 by admin in UncategorizedComments Design Therapeutics Expands Board of Directors with Key Appointments
04 Jun 2021 by admin in UncategorizedComments Arcellx Announces Presentation of Positive Clinical Results from Ongoing Phase 1 Study of CART-ddBCMA at the 2021 ASCO Annual Meeting
20 May 2021 by admin in UncategorizedComments Crescendo Biologics announces initiation of Phase 1 study of CB307 in patients with advanced, PSMA-positive solid tumours
19 May 2021 by admin in UncategorizedComments NextCure to Present Trials in Progress Poster for NC410 at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
19 May 2021 by admin in UncategorizedComments Arcellx to Present Data from Phase 1 Study of CART-ddBCMA Demonstrating Continued Positive Response in Patients with Relapsed and Refractory Multiple Myeloma at the 2021 ASCO Annual Meeting
